PARP inhibitors – theoretical basis and clinical application

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0

Abstract

Poly-ADP-ribose polymerases (PARP) are involved in a number of processes that are vital for every living cell. Once activated by the presence of DNA damage they trigger poly-ADP-ribosylation of various proteins which are crucial for DNA repair, preserving of genom integrity, regulation of transcription, proliferation and apoptosis. PARP1, which is the best known enzyme of PARP protein family, plays a role in single-strand breaks (SSB) repair. Decrease of its activity results in accumulation of single strand DNA breaks (SSB) which leads as a consequence to double- strand breaks (DSBs). This disorder is particularly harmful to cells with deficiency of BRCA1/2 protein which is involved in repair of DNA double-strand breaks. This phenomenon is an example of “synthetic lethality” concept and contributes to research on application of PARP inhibitors in treatment of cancers associated with BRCA1/2 protein defect (breast or ovarian cancer). Noticed synergism between PARP inhibitors and genotoxic chemotherapy or radiotherapy determined another direction of research on application of these medicaments. After promising results of phase I and II trials with most commonly investigated PARP inhibitors – iniparib and olaparib- which recruited patients with triple negative breast cancer and ovarian cancer, further studies started. This paper presents theoretical basis of PARP inhibitors action as well as critical review of most important clinical trials of these medicaments.

Authors and Affiliations

Sylwia Dębska, Joanna Kubicka, Rafał Czyżykowski, Maja Habib, Piotr Potemski

Keywords

Related Articles

Insulin resistance and chronic inflammation

Insulin resistance is a condition of reduced biological response to insulin. Growing evidence indicates the role of the chronic low-grade inflammatory response in the pathogenesis of insulin resistance. Adipose tissue in...

Mechanisms of angiogenesis in neoplasia

Mechanism of forming new capillary from basal vessels, named angiogenesis, exist under both physiological and pathological conditions. Initiation of this process requires imbalance between proangiogenic and antiangiogeni...

Tlenek węgla w fizjologii organizmu człowieka – rola w układzie pokarmowym

Tlenek węgla (CO) powstaje endogennie w organizmie jako produkt reakcji katalizowanej przez enzym oksygenazę hemową (HO). Z dwóch funkcjonalnych izoform HO-1 jest wysoce indukowalna i ulega ekspresji w wielu tkankach pod...

Intentional and accidental paracetamol poisoning in childhood – a retrospective analysis

Paracetamol is one of the most commonly used analgesics and antipyretics available without limits as preparations of the OTC group (over the counter drugs). Overdose and poisoning with this drug always brings about the r...

Krótkołańcuchowe kwasy tłuszczowe (SCFA) jako produkty metabolizmu bakterii jelitowych oraz ich znaczenie dla organizmu gospodarza

Bakteryjne konsorcjum jelitowe ma kluczowe znaczenie w utrzymaniu homeostazy układu odpornościowego u ssaków. Znaczącą rolę pełnią powstające w wyniku fermentacji polisacharydów metabolity bakteryjne - krótkołańcuchowe k...

Download PDF file
  • EP ID EP66698
  • DOI -
  • Views 158
  • Downloads 0

How To Cite

Sylwia Dębska, Joanna Kubicka, Rafał Czyżykowski, Maja Habib, Piotr Potemski (2012). PARP inhibitors – theoretical basis and clinical application. Advances in Hygiene and Experimental Medicine, 66(0), 311-321. https://europub.co.uk/articles/-A-66698